earnings
ND
NASDAQ · NDRA
ENDRA Life Sciences Inc.
Healthcare · Medical - Diagnostics & Research
$5.83
Down-$0.05 (-0.77%)
Updated Sep 10, 2026, 10:36 PM
SID Score
5.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 4.46M
- P/E ratio
- -0.56
- Dividend yield
- 0.00%
- 52-week range
- $2.96 – $9.85
- Volume
- 72.14K
- Avg. volume
- 305.03K
Price performance
NDRA price history
1M range · 20 trading sessions · Daily adjusted prices
NDRA closed at $5.83 after 20 trading sessions, up 30.43% for the selected period.
- Last close
- $5.83
- Period change
- +30.43%
- Period low
- $4.47
- Period high
- $6.46
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 9, 2026 | $5.77 | $6.5516 | $5.75 | $5.83 | 72.14K |
| Sep 8, 2026 | $6.0942 | $6.10 | $5.905 | $5.905 | 2.87K |
| Sep 4, 2026 | $5.70 | $6.365 | $5.70 | $6.05 | 20.58K |
| Sep 3, 2026 | $6.45 | $6.45 | $5.6662 | $5.68 | 24.54K |
| Sep 2, 2026 | $5.05 | $6.75 | $5.05 | $6.46 | 135.94K |
| Sep 1, 2026 | $5.07 | $5.65 | $4.88 | $5.27 | 396.11K |
| Aug 31, 2026 | $5.005 | $5.005 | $4.81 | $5.005 | 1.17K |
| Aug 28, 2026 | $5.59 | $5.77 | $5.005 | $5.005 | 24.53K |
| Aug 27, 2026 | $5.50 | $5.60 | $5.2842 | $5.405 | 9.88K |
| Aug 26, 2026 | $4.46 | $5.44 | $4.172 | $5.44 | 11.42K |
| Aug 25, 2026 | $4.47 | $4.97 | $4.47 | $4.75 | 13.6K |
| Aug 24, 2026 | $4.57 | $4.90 | $4.465 | $4.56 | 7.55K |
| Aug 21, 2026 | $4.63 | $4.70 | $4.19 | $4.49 | 27.44K |
| Aug 20, 2026 | $4.445 | $4.82 | $4.445 | $4.585 | 7.65K |
| Aug 19, 2026 | $4.50 | $4.62 | $4.475 | $4.52 | 15.1K |
| Aug 18, 2026 | $4.41 | $4.55 | $4.41 | $4.51 | 2.15K |
| Aug 17, 2026 | $4.47 | $4.56 | $4.42 | $4.49 | 24.43K |
| Aug 14, 2026 | $4.42 | $4.47 | $4.26 | $4.47 | 52.22K |
| Aug 13, 2026 | $4.47 | $4.47 | $4.42 | $4.47 | 10.32K |
| Aug 12, 2026 | $4.44 | $4.47 | $4.42 | $4.47 | 3.21K |
Latest NDRA news
The latest Smart Investors Daily articles mentioning NDRA.
Stock researchCompany · Financials
Loading stock research…

